A β1-AR antagonist
Related Products And Services
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Practolol

Item No. 46899

Technical Information
Formal Name
N-[4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-phenyl]-acetamide
CAS Number
6673-35-4
Molecular Formula
C14H22N2O3
Formula Weight
Purity
≥95%
A solid
DMSO: Soluble: ≥10 mg/mlEthanol: Soluble: ≥10 mg/ml
SMILES
CC(NC1=CC=C(OCC(O)CNC(C)C)C=C1)=O
InChi Code
InChI=1S/C14H22N2O3/c1-10(2)15-8-13(18)9-19-14-6-4-12(5-7-14)16-11(3)17/h4-7,10,13,15,18H,8-9H2,1-3H3,(H,16,17)
InChi Key
DURULFYMVIFBIR-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Practolol is an antagonist of the β1-adrenergic receptor (β1-AR).1 It selectively binds to the β1-AR over β2- or β3-ARs (Kds = 0.724, 10.2, and >100 µM, respectively). Practolol (2 mg/kg) inhibits epinephrine- and methyl chloroform-induced arrhythmia in anesthetized cats.2 It also inhibits isoprenaline-induced tachycardia and diastolic hypotension in anesthetized cats (ED50s = 0.158 and 1.6 mg/kg, i.v.).3 Practolol is associated with oculomucocutaneous syndrome.4 Formulations containing practolol have previously been used in the treatment of cardiac arrhythmias.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Baker, J.G. The selectivity of β-adrenoceptor antagonists at the human β1, β2 and β3 adrenoceptors. Br. J. Pharmacol. 144(3), 317-322 (2005).

    2. Basil, B., Jordan, R., Loveless, A.H., et al. A comparison of the experimental anti-arrhythmic properties of acebutolol (M and B 17,803), propranolol and practolol. Br. J. Pharmacol. 50(3), 323-333 (1974).

    3. Basil, B., Jordan, R., Loveless, A.H., et al. β-Adrenoceptor blocking properties and cardioselectivity of M & B 17,803A. Br. J. Pharmacol. 48(2), 198-211 (1973).

    4. Wright, P. Untoward effects associated with practolol administration: Oculomucocutaneous syndrome. Br. Med. J. 1(5958), 585-598 (1975).